Pharmacists in Canton, TX Accepting Medicare
9 Pharmacists found. Showing 1 - 9
 Melody Heard Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 603 E State Highway 243, Canton, TX 75103 Phone: 903-567-6578 |
Tara Lyn Duty, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1215 S Trade Days Blvd, Canton, TX 75103 Phone: 903-567-6516 Fax: 903-567-5139 |
 Billy Jack Peace Jr., RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 S Buffalo St, Canton, TX 75103 Phone: 903-567-4129 Fax: 903-567-6772 |
Lindsay Burgess, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 880 E State Highway 243, Canton, TX 75103 Phone: 903-567-2403 |
Carol Ann Johnson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 603 E State Highway 243, Canton, TX 75103 Phone: 903-567-6578 |
Mark Banks Mclarnon Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1215 S Trade Days Blvd, Canton, TX 75103 Phone: 903-567-6516 Fax: 903-567-5139 |
Dr. Adam Franklin Fischer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 603 E State Highway 243, Canton, TX 75103 Phone: 903-567-6578 |
Jan Lynne Eiland, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 S Buffalo St, Canton, TX 75103 Phone: 903-567-4129 Fax: 903-567-6772 |
Zuhair Patel Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1215 S Trade Days Blvd, Canton, TX 75103 Phone: 903-567-6516 Fax: 903-567-5139 |
News Archive
Anti-social behavior in girls predicts adolescent depression seven years later
Past behavior is generally considered to be a good predictor of future behavior, but new research indicates that may not be the case in the development of depression, particularly among adolescent girls.
BATM provides business and trading update
BATM, a leading provider of real-time technologies for networking solutions and medical laboratory systems, provides the following business and trading update.
Study explores the effects of SARS-CoV-2 (and other betacoronaviruses) on cellular mRNA processing
A new study has been released on the bioRxiv* preprint server, which deals with a comprehensive survey on alternative splicing concerning SARS-CoV-2 infection. This study has also included two other betacoronavirurses (SARS-CoV and MERS), a control set of unrelated viruses, and a bacterium, namely, Streptococcus pneumonia. The study findings suggest that several cellular parameters are affected owing to a betacoronavirus infection, which in turn affects some genes and invariably various biological functions.
Gleevec receives FDA priority review for gastrointestinal stromal tumors after surgery
Novartis has announced that Gleevec (imatinib mesylate) tablets, (known as Glivec (imatinib) outside the US, Canada and Israel), has been granted priority review status by the US Food and Drug Administration (FDA) as the first therapy to be reviewed for use after surgery in kit-positive gastrointestinal stromal tumors (GIST).
Transcept Pharmaceuticals reports financial results for the third quarter of 2009
Transcept Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in neuroscience, today announced financial results for the three and nine months ended September 30, 2009.
› Verified 4 days ago